This protocol is judged by an institutional evaluation board, an impartial group that reviews any scientific trials involving individuals. If a review will involve a Schedule I drug, when the board approves the protocol as ethical, the scientists really need to make an application for an investigational new drug (IND) amount from your FDA.When bene